Download Free Sample
Table of Contents
Chondroitin Sulfate is a Sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. Chondroitin sulfate is an important structural component important in the formation of cartilage which is found between joints (finger, knee, hip, etc). Thus, chondroitin sulfate provides much of its resistance to compression allowing for easy, painless movement. Chondroitin sulfate is usually manufactured from animal sources, such as shark and cow cartilage.
Chondroitin Sulfate has become a widely used dietary supplement for treatment of osteoarthritis. Chondroitin Sulfate is also effective for cataracts, urinary tract infections (utis), dry eyes, muscle soreness after exercise, acid reflux, painful bladder (interstitial cystitis), bone and joint disease (kashin-beck disease), heart attack, skin redness and irritation (psoriasis), overactive bladder, heart disease, weak bones (osteoporosis), high cholesterol. This is boosting investment in research and development which ultimately driving growth in this market.
North America and Europe are biggest chondroitin sulfate market due to high level of awareness amongst people and government efforts toward osteoarthritis diagnosis and its management, developed healthcare infrastructure, high prevalence of the disease in the region etc. China is the biggest chondroitin sulfate producer and exporter in the global Chondroitin Sulfate market accounting for 78% of the global market output in 2023. Most food grade exports are made to the United States while pharmaceutical grade exports are made to the Europe. Unites States is an important consumption market of Chondroitin Sulfate, enjoying 60% consumption market share in 2023.
Chondroitin Sulfate Market : Product Type
Chondroitin Sulfate Market : Application
Global Chondroitin Sulfate Market: Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of following key players in Global Chondroitin Sulfate Market:
Geographical analysis of Chondroitin Sulfate Market :
Global Chondroitin Sulfate Market Report delivers a comprehensive analysis of the following parameters:
Parameters | Details |
---|---|
Base Year |
2024 |
Historical Data |
2018-2023 |
Forecast Data |
2024-2030 |
Base Year Value (2024) |
USD 475.87 million |
Forecast Value (2031) |
USD 831.54 million |
CAGR (2025-2030) |
8.3 % |
Regional Scope |
North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW |
Chondroitin Sulfate Market was valued at around USD 475.87 million in 2023 & estimated to reach USD 831.54 million by 2030.
Chondroitin Sulfate Market is likely to grow at Compound Annual Growth Rate (CAGR) of 8.3% between 2024 to 2030.
Chondroitin Sulfate Market is dominated by the Pharmaceutical Grade segment and the North America region holds the highest market share in 2023.
Some of the top key players in the Chondroitin Sulfate Market are SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA, Huiwen, QJBCHINA, Meitek (Synutra International), Hengjie Bio-Pharmaceuticals, Nippon Zoki, GGI, Summit Nutritionals.
Primary driving factors for the growth of the Chondroitin Sulfate Market include High level of awareness amongst people and government efforts toward osteoarthritis diagnosis and its management, developed healthcare infrastructure, high prevalence of the disease in North America.
Yes, the report includes COVID 19 impact on the market.
Inquire Before Buying
We are committed to offering 100 % free customization while purchasing.
Receive a detailed insight into the Chondroitin Sulfate Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.
Download Free Sample